Tag: FDA

A total of 107 posts are filed under FDA
The corporate logo of the U.S. Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. U.S. health officials unveiled plans to fight avoidable injuries from medication errors or misuse, a problem that harms hundreds of thousands of people each year and can be deadly.    REUTERS/Jason Reed   (UNITED STATES HEALTH) - RTXQCTX
Rare Disease Report: FDA Approves Combination Letairis and Adcirca for PAH
The U.S. Food and Drug Administration (FDA) has approved the combination of Letairis (ambrisentan) and Adcirca (tadalafil) to treat patients… Continue Reading
FDA Awards 18 Grants to Stimulate Product Development for Rare Diseases
The U.S. Food and Drug Administration today announced it has awarded 18 new research grants totaling more than $19 million to boost the… Continue Reading
Screen Shot 2015-08-17 at 2.53.55 PM
Rare Disease Report: Raptor’s Cysteamine Capsule Now Approved for Children
Children with nephropathic cystinosis can now receive delayed-release cysteamine tablets. Raptor Pharmaceutical Corp announced that the U.S.… Continue Reading
Genentech on the Verge of First Biologic Treatment for Pemphigus Vulgaris
Genentech has announced the initiation of a Phase III clinical trial investigating the use of Rituxan (rituximab) in patients with pemphigus… Continue Reading
RARECast: An FDA Perspective on Rare Diseases
  The FDA Office of Orphan Products Development seeks to advance the evaluation of drugs and diagnostics to treat rare diseases. A growing… Continue Reading
Girl With Duchenne Waits for Life-Changing Drug, Eteplirsen, To Gain FDA Approval
Susie Arroyo knows she is an anomaly. The 25-year-old Pendleton woman has a genetic mutation called Duchenne Muscular Dystrophy, a… Continue Reading
Picture  courtesy of https://www.bidnessetc.com
Kids (Six and Under) With Rare Blood Disorder, Chronic ITP, Get FDA Approval on New Novartis Drug, Promacta
Promacta® (eltrombopag) significantly increased and sustained platelet counts in two studies, including the largest Phase III clinical… Continue Reading
Share Your Patient Story

Follow us on Twitter